3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
59
Other hematologic neoplasm
22
Lymphoid
8
Plasma cell
6
Breast
4
Thoracic
2
Other
2
Sarcoma
1
Gynecologic
1
Conditions
Obesity
373
Neoplasms
134
Breast Neoplasms
95
Mucositis
94
Overweight
91
Sexual Dysfunction, Physiological
90
Polycystic Ovary Syndrome
89
Dyspnea
56
Motor Activity
54
Weight Loss
38
Constipation
35
Diabetes Mellitus
33
Prostatic Neoplasms
32
Head and Neck Neoplasms
30
Colorectal Neoplasms
30
Endometrial Neoplasms
26
Lung Neoplasms
25
Depression
25
Diabetes Mellitus, Type 2
23
Cardiovascular Diseases
23
Multiple Endocrine Neoplasia Type 1
22
Pain
20
Anxiety Disorders
20
Insulin Resistance
19
Obesity, Morbid
18
Pulmonary Disease, Chronic Obstructive
17
Hypertension
17
Sexual Dysfunctions, Psychological
16
Metabolic Syndrome
16
Colonic Neoplasms
16
Interventions
Interleukin 1 Receptor Antagonist Protein
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Febrile Neutropenia
×
Other
×
Clear all
NCT03233776
2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2
Completed
9 enrolled
NCT04099901
2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2
Completed
88 enrolled